AMANDA BLANTON: Open Payments
NPI 1053398875 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,632 in 76 payments from 22 companies in 2025. Trend: 2023 $580 · 2024 $1,321 · 2025 $1,632
Food & beverage: $1,632
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $384 |
| Teva Pharmaceuticals USA, Inc. | 13 | $234 |
| Janssen Biotech, Inc. | 6 | $220 |
| E.R. Squibb & Sons, L.L.C. | 6 | $129 |
| Ardelyx, Inc. | 1 | $115 |
| Celgene Corporation | 3 | $92 |
| Madrigal Pharmaceuticals | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $38 |
Products named: AUSTEDO XR, TREMFYA, VRAYLAR, COBENFY, IBSRELA, IMBRUVICA, RINVOQ, OPDIVO.
Industry payments across SC — which companies pay providers there.
